As the Chairman of Singapore’s lead R&D public sector agency, Chorh Chuan Tan outlines A*STAR’s strategic role within a new phase of national strategic priorities in research, innovation and enterprise.
At A*STAR, precision medicine and population health are bridging disciplines to shed new light on facets of human development and well-being, enabling targeted early interventions to enhance the healthspans of Asian populations.
This year’s L’Oréal-UNESCO For Women in Science (Singapore) Awards programme recognises three women scientists for their exceptional contributions to neuroscience, infectious diseases and RNA therapeutics.